Navigation Links
Just in time for spring: Scientists find the cellular on and off switch for allergies and asthma
Date:4/30/2009

If you're one of the millions who dread the spring allergy season, things are looking up. A research study appearing in the May 2009 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) shows how a team of American scientists have identified a previously unknown cellular switch that turns allergies and asthma both on and off. Equally important, this study also suggests that at least for some people with asthma and allergies, their problems might be caused by genes that prevent this switch from working properly. Taken together, this information is an important first step toward new medications that address the root causes of allergies, asthma and other similar diseases.

"This study uncovers some of the basic mechanisms that control whether or not people have asthma and allergies and the severity of the symptoms," said John Ryan, Ph.D., Professor of Biology at Virginia Commonwealth University, and a senior scientist involved in the research. "This understanding opens new avenues for treating these and other related diseases."

Ryan and colleagues made this discovery in mouse experiments that examined cells from bone marrow and umbilical cord blood that ultimately help create a type of immune cell (mast cells). Too many mast cells lead to an over-aggressive immune response, which causes allergies and asthma. The scientists found that when chemicals (cytokines IL-4 and IL-10) used to initiate an immune response (the "on switch") are added to developing mast cells, the developing cells die. Because bone marrow makes both mast cells and these cytokines, the researchers conclude that just as the cytokines serve as the "on switch" for the immune system, bone marrow cells also use them as the "off switch" to stop mast cells from getting out of hand. Further supporting their discovery was the finding that strains of mice prone to allergies and asthma had genes which affected the production of this chemical "off switch" in their bone marrow.

"The immune system has an incredible capacity for balance and counterbalance to maintain optimal and properly tuned immune responses," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology, "The studies by Ryan and colleagues are an excellent example of this inherent self-regulation of the immune system and how an imbalance in mast cell regulation could contribute to allergy and disease."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. Geoscientists meet to discuss Rocky Mountain geology
2. Gladstone scientists identify key factors in heart cell creation
3. Fire is important part of global climate change, report scientists
4. Scientists give a hand(edness) to the search for alien life
5. Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection
6. Marine scientists warn of potential for spring, summer red tide outbreak in Gulf of Maine
7. Singapore scientists synthesize gold to shed light on cells inner workings
8. UNC study: Scientists identify chemical compound that may stop deadly brain tumors
9. Caltech scientists control complex nucleation processes using DNA origami seeds
10. Scientists identify key gene that protects against leukemia
11. Scientists develop method for comprehensive proteome analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... , March 6, 2017 ... sales technology, today announced Predictive Sales Coach TM ... infusing actionable sales intelligence into Salesforce. This unique ... enable their sales organizations with deep knowledge of ... allow for intelligent engagement. Predictive Sales Coach extends ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
(Date:3/22/2017)... ... ... Premier executive recruitment firm, Slone Partners, is proud to have been named a Top ... Hunt Scanlon Media is one of the most respected life science publications in the ... sector. , “It is a great honor for Slone Partners to be part of ...
(Date:3/22/2017)... , ... March 21, 2017 , ... The Conference Forum ... (CMO Summit) to be held on May 10-11, 2017, at the Colonnade Hotel in ... specifically for Chief Medical Officer peer-to-peer learning, benchmarking and support. , “The Chief Medical ...
(Date:3/22/2017)... and PETACH TIKVAH, Israel , March ... a leading developer of adult stem cell technologies for ... Chief Executive Officer, will provide an update on new ... nd Annual Neuroscience Biopartnering and Investment Forum, being ... York Academy of Sciences. ...
Breaking Biology Technology: